Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2013; 59(6): 3-11


New fluorine-containing openers of ATP-sensitive potassium channels flokalin and tioflokalin inhibit calcium-induced mitochondrial pore opening in rat hearts

Strutyns'ka NA, Strutyns'kyĭ RB, Chorna SV, Semenykhina OM, Mys' LA, Moĭbenko OO, Sahach VF

    O.O.Bogomoletz Institute of Physiology National Academyof Science of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz59.06.003


Abstract

In experiments in vitro on the mitochondria isolated from the rat's heart we studied the effects of the openers of ATP-sensitive potassium channels (K(ATP)-channels), flocalin and tioflocalin, on the calcium-induced mitochondrial pore (MPTP) opening. Flocalin and tioflocalin caused moderate Ca(2+)-independent mitochondria swelling, which was prevented by a specific inhibitor of 5-hydroxydecanoate. This allowed to identify these compounds as mitochondrial K(ATP)-channels openers. We found that concentration-dependent inhibitory effects (10(-7) to 10(-4) M) of flocalin (with IC50 = 50 microM) and tioflocalin (with IC50 = 2,7 microM) on Ca(2+)-induced mitochondrial swelling (MPTP opening) in the heart characterized more powerful cardioprotective action of the latter. It was shown that the administration of these compounds in experiments in vivo decreased the sensitivity of the MPTP opening to Ca2+. Thus, under physiological conditions the activators K(ATP)-channels probably provide the membrane-stabilizing effects, thereby effectively increasing the organelles resistance to Ca2+, an inductor of MPTP. The results obtained allowed to characterize the role of the compound studied as cardioprotectors and regulators of the MPTP formation in the heart, indicated their anti-ischemic and anti-apoptotic effects that can be used in order to correct the mitochondrial dysfunction under pathological conditions of the cardiovascular system.

Keywords: flocalin, tioflocalin, KATP-channels, mitochondrialpore, heart, rats.

References

  1. Moibenko A.A., Dosenko V.E., Parhomenko A.N. Endogennie mehanizmi kardioprotektsii kak osnovapatogeneticheskoi terapii zabolevanii serdtsa . K.:Nauk. dumka, 2008. 518 p.
  2.  
  3. Sagach V.F., Vavilova G.L., Strutins'ka N.A., RudikO.V. Starinnya pidvishchuie chutlivist' do induktorivmitohondrial'noi pori v sertsi shchuriv . Fiziol. zhurn. 2004. 50. N 2. P. 4963.
  4.  
  5. Strutins'ka N.A., Dorofeieva N.O., Vavilova G.L.,Sagach V.F. Pidvishchena chutlivist' mitohondrial'noipori do induktora Sa2+ u sertsi shchuriv zi spontannoyugipertenziieyu . Tam samo. 2012. 58, N 6. P. 38.
  6.  
  7. Strutins'kii R.B., Moibenko O.O., Chebanov V.A.,Gorobets' M.Yu. Modelyuvannya promislovogo protsesuvirobnitstva preparatu "Flokalin" ta viznachennyaiogo optimal'noefektivnoi dozi dlya likuvannyazahvoryuvan' sertsya . Nauka ta innovatsii. 2013. 9,N 1. P. 5563.
  8.  
  9. Strutins'kii R.B., Moibenko O.O., Yagupol's'kiiL.M., Yuz'kiv M.Ya., Kvochina L.I., Shish A.M. Doslidzhennya kardioprotektornih efektiv novogo ftormisnogo aktivatora ATFzalezhnih kaliievih kanaliv .Fiziol. zhurn. 2001. 47, N 2. P. 1623.
  10.  
  11. Strutins'kii R.B., Nagibin V.S., Strutins'ka N.A.,Yanchii O.P., Moibenko O.O. Vpliv flokalinu na rozvitok apoptozu ta nekrozu pri anoksiireoksigenatsiiizol'ovanih neonatal'nih kardiomiotsitiv . Tam samo. 2013. 59, N 3. P. 39.
  12.  
  13. Auchampach J., Grover G., Gross G. Blockade of ischemicpreconditioning in dogs by the novel ATPdependentpotassium channel antagonism sodium 5hydroxydecanoate. Cardiovascular. Res. 1992 26, N 11. P. 10541062. CrossRef  
  14. Bhatnagar A., Bolli R. Modulation of KATP channels toprotect the ischemic myocardium: Clinical implications. Exp. Clin. Cardiol. 1999. 4, N 1. P. 2022.
  15.  
  16. Cheng Y, DebskaVielhaber G, Siemen D.Interaction ofmitochondrial potassium channels with the permeabilitytransition pore . FEBS Lett. 2010. 584, N 10 P. 20052012. CrossRef PubMed
  17.  
  18. Di Lisa F., Carpi A., Giorgio V., Bernardi P. The mitochondrialpermeability transition pore and cyclophilin D incardioprotection . Biochim. and Biophys. Acta. 2011. 1813, N 7. P. 13161322.
  19.  
  20. Elrod J.W., Molkentin J.D. Physiologic functions of cyclophilinD and the mitochondrial permeability transitionpore . Ibid. 2013 77, N 5 P. 11111122.
  21.  
  22. Gross G.J., Auchampach J.A. Blockade of ATPsensitivepotassium channels prevents myocardial preconditioningin dogs . Ibid. 1992. 70. P.223233.
  23.  
  24. Gross G.J., Fryer R.M. Sarcolemmal versus mitochondrialATPsensitive K+ channels and myocardial preconditioning. Ibid. 1999. 84, N 9. P. 973979.
  25.  
  26. Hanley P.J., Daut J. K(ATP) channels and preconditioning:a reexamination of the role of mitochondrial K(ATP)channels and an overview of alternative mechanisms. J. Mol. Cell. Cardiol. 2005. 39, N 1. P. 1750. CrossRef PubMed
  27.  
  28. Holmuhamedov E.L., Wang L., Terzic A. ATPsensitiveK+ channel openers prevent Ca2+ overload in rat cardiacmitochondria . J. Physiol. (London). 1999. 519,N 2. P. 347360. CrossRef PubMedCentral
  29.  
  30. Inoue I., Nagase H., Kishi K., Higuti T. ATPsensitive K+Novi ftorvmisni aktivatori adenozintrifosfatchutlivihkaliievih kanalivISSN 02018489 Fiziol. zhurn., 2013, T. 59, N 6 11channels in the mitochondrial inner membrane . Nature. 1991. 352, N 6332. P. 244247.
  31.  
  32. Jahandir A., Terzic A. KATP channel therapeutics at the bedside. J. Molec. and Cell. Cardiol. 2005. 39. P. 99112.
  33.  
  34. Noma A. ATPregulated K+ channels in cardiac muscle. Nature. 1983. 305, N 5930. P. 147148. CrossRef  
  35. Voitychuk O.I., Strutynskyi R.B., Yagupolskii L.M., TinkerA., Moibenko O.O., Shuba Y.M. Sarcolemmal cardiacKATP channels as a target for the cardioprotective effectsof the fluorinecontaining pinacidil analogue flocalin. Brit. J. Pharmacol. 2011. 162, N 3. P. 701711. CrossRef PubMed PubMedCentral
  36.  
  37. Wakahara N., Katoh H., Yaguchi Y., Uehara A., Satoh H.,Terada H., Fujise Y., Hayashi H., Difference in the cardioprotectivemechanisms between Ischemic preconditioningand pharmacological preconditioning by diazoxidein rat hearts . Circular. J. 2004. 68. P. 156162. CrossRef  
  38. Webster K.A. Mitochondrial membrane permeabilizationand cell death during myocardial infarction: roles ofcalcium and reactive oxygen species . Future Cardiol. 2012. 8, N 6 P 863884. CrossRef PubMed PubMedCentral
  39.  
  40. Yagupolskii L.M., Maletina I.I., Petko K.I. New fluorinecontaininghypotensive preparations . J. Fluor. Chem.2001. 109. P.8794.
  41.  
  42. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M.,Cohen M.V. Multiple, brief coronary occlusions duringearly reperfusion protect rabbit hearts by targeting cellsignaling pathways . J. Amer. Coll Cardiol. 2004. 44,N 5. P. 11031110. CrossRef PubMed
  43.  

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.